Evidence map›Paper›PMID 30380745›Full record

ArticleMolecules (Basel, Switzerland)2018

Lupeol, a Pentacyclic Triterpene, Promotes Migration, Wound Closure, and Contractile Effect In Vitro: Possible Involvement of PI3K/Akt and p38/ERK/MAPK Pathways.

Fernando Pereira Beserra, Meilang Xue, Gabriela Lemos de Azevedo Maia, Ariane Leite Rozza, Cláudia Helena Pellizzon, Christopher John Jackson

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Bioactivity-Guided Isolation of Stigmasterol fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Ang-1 and VEGF: central regulators of angiogenesis.Molecular and cellular biochemistry · 2025
    Review
  12. Article
  13. Investigation of theFrontiers in pharmacology · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Fernando Pereira BeserraDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil. fernando.beserra@unesp.br.
Meilang XueSutton Research Laboratory, Kolling Institute of Medical Research, the University of Sydney at Royal North Shore Hospital, St Leonard, NSW 2065, Australia. meilang.xue@sydney.edu.au.
Gabriela Lemos de Azevedo MaiaDepartment of Pharmacy, Federal University of São Francisco Valley (UNIVASF), Petrolina 56304-205, Pernambuco, Brazil. gabriela.lam@gmail.com.
Ariane Leite RozzaDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil. arianerozza@gmail.com.ORCID 0000-0002-4198-0135
Cláudia Helena PellizzonDepartment of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil. claudia.pellizzon@gmail.com.ORCID 0000-0002-4494-4180
Christopher John JacksonSutton Research Laboratory, Kolling Institute of Medical Research, the University of Sydney at Royal North Shore Hospital, St Leonard, NSW 2065, Australia. chris.jackson@sydney.edu.au.ORCID 0000-0002-9234-9116
Universidade Estadual Paulista (Unesp) · BRThe University of Sydney · AUUniversidade Federal do Vale do São Francisco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin wound healing is a dynamic and complex process involving several mediators at the cellular and molecular levels. Lupeol, a phytoconstituent belonging to the triterpenes class, is found in several fruit plants and medicinal plants that have been the object of study in the treatment of various diseases, including skin wounds. Various medicinal properties of lupeol have been reported in the literature, including anti-inflammatory, antioxidant, anti-diabetic, and anti-mutagenic effects. We investigated the effects of lupeol (0.1, 1, 10, and 20 μg/mL) on in vitro wound healing assays and signaling mechanisms in human neonatal foreskin keratinocytes and fibroblasts. Results showed that, at high concentrations, Lupeol reduced cell proliferation of both keratinocytes and fibroblasts, but increased in vitro wound healing in keratinocytes and promoted the contraction of dermal fibroblasts in the collagen gel matrix. This triterpene positively regulated matrix metalloproteinase (MMP)-2 and inhibited the NF-κB expression in keratinocytes, suggesting an anti-inflammatory effect. Lupeol also modulated the expression of keratin 16 according to the concentration tested. Additionally, in keratinocytes, lupeol treatment resulted in the activation of Akt, p38, and Tie-2, which are signaling proteins involved in cell proliferation and migration, angiogenesis, and tissue repair. These findings suggest that lupeol has therapeutic potential for accelerating wound healing.

Indexed as

Cell MovementCell ProliferationFibroblastsGene Expression RegulationHumansKeratin-16KeratinocytesLupanesMatrix Metalloproteinase 2NF-kappa Bp38 Mitogen-Activated Protein KinasesPentacyclic TriterpenesProto-Oncogene Proteins c-aktReceptor, TIE-2Signal TransductionWound HealingKeratin-16LupaneslupeolMatrix Metalloproteinase 2MMP2 protein, humanNF-kappa Bp38 Mitogen-Activated Protein KinasesPentacyclic TriterpenesProto-Oncogene Proteins c-aktReceptor, TIE-2TEK protein, humancell migrationfibroblastskeratinocyteslupeolwound healing

Identifiers

PMID30380745
PMCPMC6278408
OpenAlexW2899421833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.